Article
rpoB mutations in Streptococcus mitis clinical isolates resistant to rifampin.
Antimicrobial agents and chemotherapy - 1 Jul 2004
Achour Wafa, Guenni Olfa, Fines Marguerite, Leclercq Roland, Ben Hassen Assia
Abstract excerpt
Activity of rifampin against 129 Streptococcus mitis isolates obtained from patients with hematologic cancer was investigated. One hundred twenty-five strains were susceptible to rifampin, and 4 were resistant (MIC = 32 to 64 microg/ml). Resistance to rifampin was related to mutations in the rpoB...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
